An increase of the DPP-IV enzymatic activity accompanied by a shift from acidic to more neutral glycoforms of the circulating DPP-IV was previously observed in RA patients with clinical improvement after anti TNF alpha therapy [31]. The gene discussed is TNF; the disease is rheumatoid arthritis.